SCHEDULE 13G

Company

ORAMED PHARMACEUTICALS INC.

Filed

February 11, 2020

Accession Number

0001213900-20-003270

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →